Literature DB >> 18428984

High-throughput phase-distribution method to determine drug-cyclodextrin binding constants.

Zhi Chen1, Dujuan Lu, Stephen G Weber.   

Abstract

A high-throughput method has been developed to measure drug-cyclodextrin binding constants. It measures the distribution ratio of a drug between a polymer film [polyvinyl chloride (PVC) with 67% (w/w) dioctyl sebacate (DOS)] and a cyclodextrin-containing buffer in a 96-well format. Measurements of distribution ratios at several cyclodextrin concentrations lead to binding constants. Binding constants for econazole with six CDs have been determined in one 96-well microplate with four replications of each condition in 10 h. The K(1:1)/10(3) M(-1) values are 3.98 +/- 0.13, 3.90 +/- 0.22, 29.3 +/- 2.2, 0.66 +/- 0.04, 1.78 +/- 0.30, 4.08 +/- 0.50, with (2-hydroxyethyl)-beta-cyclodextrin, (2-hydroxypropyl)-beta-cyclodextrin, 2,6-di-O-methyl-beta-cyclodextrin, heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, alpha-cyclodextrin, beta-cyclodextrin, respectively. It is likely that 1:2 complexes are also formed in some cases. This method has also been applied to study the binding behavior as a function of the drug concentration and pH. Binding weakens at higher drug concentration which may be due to the self-association of the drug. An acidic environment decreases the binding constant of CD with the basic econazole. The formation of the 1:2 complexes is completely suppressed in acid as well. This protocol is faster than the phase-solubility method. Moreover, the material requirement is up to four orders of magnitude lower. (c) 2008 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18428984      PMCID: PMC2759112          DOI: 10.1002/jps.21396

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

1.  Symmetry breaking during the formation of beta-cyclodextrin-imidazole inclusion compounds: capillary electrophoresis study.

Authors:  Y C Guillaume; E Peyrin
Journal:  Anal Chem       Date:  1999-05-15       Impact factor: 6.986

2.  Industrial Applications of Cyclodextrins.

Authors:  Allan R. Hedges
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

3.  High-throughput assay for determining specificity and affinity of protein-DNA binding interactions.

Authors:  Outi Hallikas; Jussi Taipale
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Study on the inclusion complexes of bromazepam with beta- and beta-hydroxypropyl-cyclodextrins.

Authors:  H A Archontaki; M V Vertzoni; M H Athanassiou-Malaki
Journal:  J Pharm Biomed Anal       Date:  2002-05-15       Impact factor: 3.935

5.  Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.

Authors:  Szabolcs Béni; Zoltán Szakács; Orsolya Csernák; Lajos Barcza; Béla Noszál
Journal:  Eur J Pharm Sci       Date:  2006-11-07       Impact factor: 4.384

6.  Artificial receptor-facilitated solid-phase microextraction of barbiturates.

Authors:  S Li; L Sun; Y Chung; S G Weber
Journal:  Anal Chem       Date:  1999-06-01       Impact factor: 6.986

7.  Determination of the binding constant between alprostadil and alpha-cyclodextrin by capillary electrophoresis: implications for a freeze-dried formulation.

Authors:  Benjamin R Schipper; Tore Ramstad
Journal:  J Pharm Sci       Date:  2005-07       Impact factor: 3.534

8.  Enhanced extraction of phenobarbital from serum with a designed artificial receptor.

Authors:  J N Valenta; R P Dixon; A D Hamilton; S G Weber
Journal:  Anal Chem       Date:  1994-07-15       Impact factor: 6.986

9.  When can cyclodextrins be considered for solubilization purposes?

Authors:  Venkatramana M Rao; Valentino J Stella
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

10.  Investigation of drug-cyclodextrin complexes by a phase-distribution method: some theoretical and practical considerations.

Authors:  Már Másson; Birna Vigdís Sigurdardóttir; Kristján Matthíasson; Thorsteinn Loftsson
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-08       Impact factor: 1.645

View more
  1 in total

1.  Lipophilicity screening of novel drug-like compounds and comparison to clog P.

Authors:  Dujuan Lu; Peter Chambers; Peter Wipf; Xiang-Qun Xie; Danielle Englert; Stephen Weber
Journal:  J Chromatogr A       Date:  2012-08-01       Impact factor: 4.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.